BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19509226)

  • 1. Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women.
    Brown KA; McInnes KJ; Hunger NI; Oakhill JS; Steinberg GR; Simpson ER
    Cancer Res; 2009 Jul; 69(13):5392-9. PubMed ID: 19509226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase.
    Brown KA; Hunger NI; Docanto M; Simpson ER
    Breast Cancer Res Treat; 2010 Sep; 123(2):591-6. PubMed ID: 20300828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and breast cancer: progress to understanding the relationship.
    Brown KA; Simpson ER
    Cancer Res; 2010 Jan; 70(1):4-7. PubMed ID: 20028864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.
    Chand AL; Herridge KA; Howard TL; Simpson ER; Clyne CD
    Steroids; 2011 Jul; 76(8):741-4. PubMed ID: 21392518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREB-regulated transcription co-activator family stimulates promoter II-driven aromatase expression in preadipocytes.
    Samarajeewa NU; Docanto MM; Simpson ER; Brown KA
    Horm Cancer; 2013 Aug; 4(4):233-41. PubMed ID: 23584792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
    Ghosh S; Lu Y; Katz A; Hu Y; Li R
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
    Zhou D; Zhou C; Chen S
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
    Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
    Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of aromatase expression in the human adipocyte cell line SGBS.
    McInnes KJ; Brown KA; Knower KC; Chand AL; Clyne CD; Simpson ER
    Breast Cancer Res Treat; 2008 Dec; 112(3):429-35. PubMed ID: 18181018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene.
    Zhou D; Chen S
    Arch Biochem Biophys; 1999 Nov; 371(2):179-90. PubMed ID: 10545204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter-specific effects of metformin on aromatase transcript expression.
    Samarajeewa NU; Ham S; Yang F; Simpson ER; Brown KA
    Steroids; 2011 Jul; 76(8):768-71. PubMed ID: 21414336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
    Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
    Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
    Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
    Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.
    Kijima I; Phung S; Hur G; Kwok SL; Chen S
    Cancer Res; 2006 Jun; 66(11):5960-7. PubMed ID: 16740737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells.
    Kijima I; Ye J; Glackin C; Chen S
    Cancer Res; 2008 Jun; 68(11):4455-64. PubMed ID: 18519709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer.
    Zhou J; Suzuki T; Kovacic A; Saito R; Miki Y; Ishida T; Moriya T; Simpson ER; Sasano H; Clyne CD
    Cancer Res; 2005 Jan; 65(2):657-63. PubMed ID: 15695411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.
    Samarajeewa NU; Yang F; Docanto MM; Sakurai M; McNamara KM; Sasano H; Fox SB; Simpson ER; Brown KA
    Breast Cancer Res; 2013 Apr; 15(2):R30. PubMed ID: 23566437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
    Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.